The FDA has no direct precedent for reviewing a glucagon agonist for chronic weight management
Verhoog de vetstofwisseling
When activated, this receptor triggers several responses throughout the body
Chronic systemic inflammation is also associated with elevated lipolysis in white adipose tissue and lipogenesis in nonadipose tissues, causing ectopic fat deposition in nonadipose tissues and imbalance in free fatty acid homeostasis and increased risk of IR [63]
Its not rocket science, but it takes a lot of engagement, consistency, practice and personal knowledge to get it right for your body
Your cardiologist can help you evaluate the potential benefits and risks based on your heart health, medical history, and weight loss goals